Navigation Links
InspireMD Boosts MGuard Production Capacity

TEL AVIV, Israel, March 2, 2011 /PRNewswire/ --

InspireMD, developer of the MGuard™ net protective stent system, has expanded its MGuard production facilities to meet the steady increase in demand.  The driving forces behind the accelerating demand for MGuard include the recent recommendation of the European Society of Cardiology (ESC) mesh-based protection to be considered for PCI of highly thrombotic or SVG lesions. Currently, this type of approved mesh technology is exclusively produced by InspireMD in its unique MGuard™ mesh protected coronary stent system.  Greater awareness of the MGuard solution among interventional cardiologists worldwide has been contributing to increased MGuard sales. To accommodate this increased demand, InspireMD has enlarged its production workforce and invested in new crimping machinery that can double InspireMD's previous production capacity.

"Based on our last published financial results, for the nine months ended September 30, 2010, our sales have increased more than 100% compared to the same period in 2009, and with this growth in mind, we have expanded to meet increased production demand," said Eli Bar, CTO and VP R&D at InspireMD. "When we evaluated the success criteria for our investment in advanced crimping machinery, it was important to us that we would be able to increase production capacity by a factor of two. With our expanded facilities, we have experienced an even larger increase of our production capacity, and we are able to achieve constant output of a homogenous product of optimal quality."

"One of the main success factors of our business is our ability to produce and deliver our high quality products to match demand," stated Ofir Paz, CEO of InspireMD. "We are very pleased to see that our MGuard solution is becoming widely accepted as the preferred alternative for thrombus management in heart attack patients. The current expansion is the beginning of a major expansion in our production designed to meet the continued upward demand for MGuard solutions worldwide."

About MGuard™ CoronaryMGuard™ presents a novel combination of a coronary stent merged with an embolic protection specifically designed for Acute MI patients. The embolic protection is comprised of an ultra-thin polymer mesh sleeve that wraps the stent. The MGuard™ coronary stent provides permanent embolic protection, without affecting deliverability. MGuard™ is CE Mark approved. Mesh-based protection is now recommended for use in the recent Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC). The MGuard™ innovative concept has enjoyed an enthusiastic welcome from leading interventional cardiologists around the world.

About InspireMD Ltd.InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures.Contact Jonina OhayonMarketing +972-52-5791120

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
4. Prolong Pharmaceuticals Boosts Executive Team
5. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
6. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
7. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
8. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
9. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
10. MGuard(TM) Coronary Stent System Approved in Israel
11. Cypin Production Announces Launch of U.S./China BioPharma Conference:
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):